In cervical carcinoma, RECK expression is associated with the recruitment of tumor-infiltrating lymphocytes and the expression of immune checkpoint molecules, including programmed cell death ligand 1 (PD-L1). This evidence concerns the gene CD274 and cervical carcinoma.